← FDA DRUG APPROVALS

FDA ANDA · ANDA209285

CLONIDINE HYDROCHLORIDE

Sponsor: CHARTWELL RX

APPLICATION
ANDA209285
TYPE
ANDA
ORIGINAL APPROVAL
2017-10-23
LATEST ACTION
2020-05-21
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Prescription

Products

CLONIDINE HYDROCHLORIDEPrescription
CLONIDINE HYDROCHLORIDE 0.1MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2020-05-21Labeling · Supplement 3 · standardAP
2020-05-21Labeling · Supplement 1 · standardAP
2017-10-23UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →